Pfizer CEO Albert Bourla tests positive for Covid, says has very mild symptoms

Pfizer Inc Chief Executive Officer Albert Bourla said on Monday he had tested positive for COVID-19 and was experiencing very mild symptoms.

Bourla said he had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions.

Paxlovid is an antiviral medication that is used to treat high-risk patients, such as older people.


Bourla has received four doses of the COVID vaccine developed by Pfizer and its German partner BioNTech.